Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

ACROBiosystems CHO/Human Mesothelin Stable Cell Line, Adherent, 2/Pk.

Catalog No. 502718941
Encompass_Preferred

The CHO/Human Mesothelin Stable Cell Line is an engineered cell line expressing full-length human Mesothelin (Uniprot: Q13421-1). This cell line is designed to mimic cancer target cells for research and bioassay development applications, with surface expression of Mesothelin validated via flow cytometry.

  • Engineered to express full-length human Mesothelin
  • Surface expression confirmed by flow cytometry
  • Validated for use in cell-based Mesothelin binding assays
  • Adherent growth properties
  • Stringent quality control including negative mycoplasma and sterility testing
  • Supplied in serum-free cryopreservation medium

Catalog No. 50-271-8941 Supplier ACROBiosystems Supplier No. SCCHOATP1202VIALS
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

The CHO/Human Mesothelin Stable Cell Line is an engineered cell line expressing full-length human Mesothelin (Uniprot: Q13421-1). This cell line is designed to mimic cancer target cells for research and bioassay development applications, with surface expression of Mesothelin validated via flow cytometry.

  • Engineered to express full-length human Mesothelin
  • Surface expression confirmed by flow cytometry
  • Validated for use in cell-based Mesothelin binding assays
  • Adherent growth properties
  • Stringent quality control including negative mycoplasma and sterility testing
  • Supplied in serum-free cryopreservation medium

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.